Therefore, because the COPD population has a clear risk of cardiovascular events and a higher prevalence of subclinical atherosclerosis [27–29], it was thought that one relevant aspect would be the evaluation of PARC expression in the intercostal arteries as a representation of systemic circulation in COPD subjects. This evidence concerns the gene CCL18 and atherosclerosis.